Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

Go back to Oncolytics Biotech® Reports First Quarter 2024 Financial Results and Operational Highlights

Oncolytics Biotech (ONCY) Tops Q1 EPS by 2c

May 9, 2024 4:28 PM EDT

Oncolytics Biotech (NASDAQ: ONCY) reported Q1 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

... More